These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26921239)

  • 21. Trends in malaria morbidity following the introduction of artesunate plus amodiaquine combination in M'lomp village dispensary, south-western Senegal.
    Sarrassat S; Senghor P; Le Hesran JY
    Malar J; 2008 Oct; 7():215. PubMed ID: 18950485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda.
    Ampadu HH; Asante KP; Bosomprah S; Akakpo S; Hugo P; Gardarsdottir H; Leufkens HGM; Kajungu D; Dodoo ANO
    Malar J; 2019 Feb; 18(1):36. PubMed ID: 30736864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, comparative study of supervised and unsupervised artesunate-amodiaquine, for the treatment of uncomplicated malaria in Ghana.
    Oduro AR; Anyorigiya T; Anto F; Amenga-Etego L; Ansah NA; Atobrah P; Ansah P; Koram K; Hodgson A
    Ann Trop Med Parasitol; 2008 Oct; 102(7):565-76. PubMed ID: 18817597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Ibrahium AM; Kheir MM; Osman ME; Khalil IF; Alifrangis M; Elmardi KA; Malik EM; Adam I
    Ann Trop Med Parasitol; 2007 Jan; 101(1):15-21. PubMed ID: 17244406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profile of adverse events in patients receiving treatment for malaria in urban Ghana: a cohort-event monitoring study.
    Dodoo AN; Fogg C; Nartey ET; Ferreira GL; Adjei GO; Kudzi W; Sulley AM; Kodua A; Ofori-Adjei D
    Drug Saf; 2014 Jun; 37(6):433-48. PubMed ID: 24788801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Accuracy and Perception of Test-Based Management of Malaria at Private Licensed Chemical Shops in the Middle Belt of Ghana.
    Kwarteng A; Malm KL; Febir LG; Tawiah T; Adjei G; Nyame S; Agbokey F; Twumasi M; Amenga-Etego S; Danquah DA; Bart-Plange C; Owusu-Agyei S; Asante KP
    Am J Trop Med Hyg; 2019 Feb; 100(2):264-274. PubMed ID: 30652659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
    Akoria OA; Arhuidese IJ
    Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT.
    Willcox ML; Graz B; Diakite C; Falquet J; Dackouo F; Sidibe O; Giani S; Diallo D
    Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):23-31. PubMed ID: 21056445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
    Tarimo DS; Malekela DA
    East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informal workers' access to health care services: findings from a qualitative study in the Kassena-Nankana districts of Northern Ghana.
    Akazili J; Chatio S; Ataguba JE; Agorinya I; Kanmiki EW; Sankoh O; Oduro A
    BMC Int Health Hum Rights; 2018 May; 18(1):20. PubMed ID: 29769071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community acceptability of Seasonal Malaria Chemoprevention of morbidity and mortality in young children: A qualitative study in the Upper West Region of Ghana.
    Chatio S; Ansah NA; Awuni DA; Oduro A; Ansah PO
    PLoS One; 2019; 14(5):e0216486. PubMed ID: 31100072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA).
    Ampadu HH; Dodoo ANO; Bosomprah S; Akakpo S; Hugo P; Gardarsdottir H; Leufkens HGM; Kajungu D; Asante KP
    Drug Saf; 2018 Sep; 41(9):871-880. PubMed ID: 29696507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and perceptions of implementing mass testing, treatment and tracking in malaria control: a qualitative study in Pakro sub-district of Ghana.
    Ndong IC; Okyere D; Enos JY; Amambua-Ngwa A; Merle CSC; Nyarko A; Koram KA; Ahorlu CS
    BMC Public Health; 2019 Jun; 19(1):695. PubMed ID: 31170964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana.
    Aborah S; Akweongo P; Adjuik M; Atinga RA; Welaga P; Adongo PB
    Malar J; 2013 Jul; 12():266. PubMed ID: 23902654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of Artemisinin Derivatives in the First Trimester of Pregnancy: A Controversial Story.
    D'Alessandro S; Menegola E; Parapini S; Taramelli D; Basilico N
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32752056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting.
    Kiguba R; Ndagije HB; Nambasa V; Manirakiza L; Kirabira E; Serwanga A; Olsson S; Speybroeck N; Mukonzo J
    Malar J; 2020 Nov; 19(1):389. PubMed ID: 33143714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What determines providers' stated preference for the treatment of uncomplicated malaria?
    Mangham-Jefferies L; Hanson K; Mbacham W; Onwujekwe O; Wiseman V
    Soc Sci Med; 2014 Mar; 104():98-106. PubMed ID: 24581067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana.
    Akazili J; Chatio S; Achana FS; Oduro A; Kanmiki EW; Baiden F
    BMC Res Notes; 2016 Mar; 9():139. PubMed ID: 26936043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soft targets or partners in health? Retail pharmacies and their role in Tanzania's malaria control program.
    Kamat VR; Nyato DJ
    Soc Sci Med; 2010 Aug; 71(3):626-633. PubMed ID: 20621751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.